NR1H4 and metabolic dysfunction-associated steatohepatitis: The farnesoid X receptor (FXR) is a bile acid receptor and its agonist, obeticholic acid, improves insulin sensitivity and exhibits anti-inflammatory and antifibrotic effects in mouse models of NASH and human tissues [121,122].